Skip to content
AboutFrameworkInitiativesRM3PeopleEventsResources
Collaborate

Justified confidence in medical product safety and effectiveness.

Independent nonprofit neutral platform. MPSEI is a trademark of Medical Product Safety & Effectiveness Institute.

info@mpsei.org

Institute

  • About
  • Framework
  • People

Work

  • Initiatives
  • RM3
  • Events
  • Resources

Governance

  • RM3 antitrust statement
  • Collaborate
  • Contact

Medical Product Safety & Effectiveness Institute

PrivacyTermsAccessibility

Risk Management Maturity Model

OverviewModelGovernancePeopleUpdates

RM3 governance

RM3 governance defines roles for strategic leadership, technical alignment, framework development, domain content, and broad review.

Solid blue paths show strategic guidance moving downward through the tiers. Dashed navy paths show evidence, technical recommendations, and review feedback returning upward. Green nodes mark selected resolved feedback.

  1. 01

    Co-Chairs

    senior industry leaders who provide executive-level guidance, strategic direction, and advocacy for the Risk Management Maturity Model

    Less than half an hour monthly

  2. 02

    Technical Advisors

    global thought leaders and standards experts who help ensure RM3 stays aligned with global risk management related initiatives

    Less than 1 hour monthly

  3. 03

    Core Team

    designs the maturity model framework across domains, with each member leading a sub-team that develops the detailed content of a particular domain

    Less than 3 hours monthly

  4. 04

    Domain Sub-Teams

    subject matter experts who join organized sub-team reviews and contribute content within focused domains

    Less than 2 hours monthly

  5. 05

    General Reviewers

    provide feedback on the overall RM3 framework and deliverables

    Less than 1 hour monthly

RM3 governance tiers as an illustrated operating structure.
Antitrust

Antitrust statement

This group includes members who may be competitors or potential competitors in certain products or services. All participants acknowledge and agree to comply fully with applicable antitrust laws. In particular, the group will not engage in any discussions or reach any agreements that could restrict competition, including the sharing of competitively sensitive information such as pricing, costs, margins, confidential R&D or non-public strategic plans. Members are expected to remain vigilant and report any concerns regarding compliance with the antitrust laws.

Participation

Participation reflects individuals, not corporate endorsement.